Expression of the serine protease inhibitor neuroserpin in cells of the human myeloid lineage

 

 Buy Article Permissions and Reprints

Summary

Myeloid progenitors in the bone marrow differentiate into most of the major cell types of the immune system, including macrophages and dendritic cells. These cells play important roles in both innate and adaptive immunity. They express a number of proteases and protease inhibitors including members of the serine proteinase inhibitor or serpin superfamily. In this study we report the differential expression of neuroserpin in cells of the human myeloid lineage. Neuroserpin was highly expressed and secreted following the differentiation of monocytes to macrophages and dendritic cells. Activation of dendritic cells with lipopolysaccharide resulted in increased neuroserpin mRNA levels but no neuroserpin secretion. Confocal immunofluorescence microscopy showed neuroserpin was differentially localised in human myeloid cells. In macrophages and dendritic cells it was concentrated in vesicles located in close proximity to the plasma membrane. The majority of activated dendritic cells also exhibited an intracellular focal concentration of neuroserpin which co-localised with the lysosomal/late endosomal marker LAMP-1. As neuroserpin inhibits tissue plasminogen activator, a comparative analysis of tPA and plasminogen activator inhibitor-1 (PAI-I) expression was undertaken. This analysis revealed differential expression of PAI-I and neuroserpin suggesting they may have different functions in human immune cells.

• References

• 1 Dellas C, Loskutoff DJ. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 2005; 93: 631-640.
  Article in Thieme ConnectPubMedGoogle Scholar
• 2 Ellis V. Plasminogen activation at the cell surface. Curr Top Dev Biol 2003; 54: 263-312.
  PubMedGoogle Scholar
• 3 Nicholl SM, Roztocil E, Davies MG. Plasminogen activator system and vascular disease. Curr Vas Pharmacol 2006; 4: 101-116.
  PubMedGoogle Scholar
• 4 Miranda E, Lomas DA. Neuroserpin: a serpin to think about. Cell Mol Life Sci 2006; 63: 709-722.
  CrossrefPubMedGoogle Scholar
• 5 Osterwalder T, Contartese J, Stoeckli ET. et al. Neuroserpin, an axonally secreted serine protease inhibitor. EMBO J 1996; 15: 2944-2953.
  PubMedGoogle Scholar
• 6 Hastings GA, Coleman TA, Haudenschild CC. et al. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J Biol Chem 1997; 272: 33062-33067.
  CrossrefPubMedGoogle Scholar
• 7 Osterwalder T, Cinelli P, Baici A. et al. The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin. J Biol Chem 1998; 273: 2312-2321.
  CrossrefPubMedGoogle Scholar
• 8 Hill RM, Parmar PK, Coates LC. et al. Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells. Biochem J 2000; 345: 595-601.
  CrossrefPubMedGoogle Scholar
• 9 Krueger SR, Ghisu GP, Cinelli P. et al. Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse. J Neurosci 1997; 17: 8984-8996.
  CrossrefPubMedGoogle Scholar
• 10 Madani R, Kozlov S, Akhmedov A. et al. Impaired explorative behavior and neophobia in genetically modified mice lacking or overexpressing the extracellular serine protease inhibitor neuroserpin. Mol Cell Neurosci 2003; 23: 473-494.
  CrossrefPubMedGoogle Scholar
• 11 Zhang Z, Zhang L, Yepes M. et al. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation 2002; 106: 740-745.
  CrossrefPubMedGoogle Scholar
• 12 Lebeurrier N, Liot G, Lopez-Atalaya JP. et al. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo. Mol Cell Neurosci 2005; 30: 552-558.
  CrossrefPubMedGoogle Scholar
• 13 de Groot DM, Pol C, Martens GJ. Comparative analysis and expression of neuroserpin in Xenopus laevis. Neuroendocrinology 2005; 82: 11-20.
  CrossrefPubMedGoogle Scholar
• 14 Hasumi H, Ishiguro H, Nakamura M. et al. Neuroserpin (PI-12) is upregulated in high-grade prostate cancer and is associated with survival. Int J Cancer 2005; 115: 911-916.
  CrossrefPubMedGoogle Scholar
• 15 Gveric D, Herrera B, Petzold A. et al. Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors. Brain 2003; 126: 1590-1598.
  CrossrefPubMedGoogle Scholar
• 16 Miranda E, Romisch K, Lomas DA. Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum. J Biol Chem 2004; 279: 28283-28291.
  CrossrefPubMedGoogle Scholar
• 17 Schedel J, Distler O, Woenckhaus M. et al. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis. Ann Rheum Dis 2004; 63: 1205-1211.
  CrossrefPubMedGoogle Scholar
• 18 Kramer MD, Reinartz J, Brunner G. et al. Plasmin in pericellular proteolysis and cellular invasion. Invasion Metastasis 1994; 14: 210-222.
  PubMedGoogle Scholar
• 19 Garcia-Touchard A, Henry TD, Sangiorgi G. et al. Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol 2005; 25: 1119-1127.
  CrossrefPubMedGoogle Scholar
• 20 Irving JA, Pike RN, Lesk AM. et al. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function.[see comment]. Genome Res 2000; 10: 1845-1864.
  CrossrefPubMedGoogle Scholar
• 21 Galliciotti G, Sonderegger P. Neuroserpin. Front Biosci 2006; 11: 33-45.
  CrossrefPubMedGoogle Scholar
• 22 Castellote JC, Grau E, Linde MA. et al. Detection of both type 1 and type 2 plasminogen activator inhibitors in human monocytes. Thromb Haemost 1990; 63: 67-71.
  Article in Thieme ConnectPubMedGoogle Scholar
• 23 Hamilton JA, Whitty GA, Wojta J. et al. Regulation of plasminogen activator inhibitor-1 levels in human monocytes. Cell Immunol 1993; 152: 7-17.
  CrossrefPubMedGoogle Scholar
• 24 Hart PH, Vitti GF, Burgess DR. et al. Human monocytes can produce tissue-type plasminogen activator. J Exp Med 1989; 169: 1509-1514.
  CrossrefPubMedGoogle Scholar
• 25 Lee HK, Hsu AK, Sajdak J. et al. Coexpression analysis of human genes across many microarray data sets. Genome Res 2004; 14: 1085-1094.
  CrossrefPubMedGoogle Scholar
• 26 Badola S, Spurlinga H, Robisona K. et al. Correlation of serpin–protease expression by comparative analysis of real-time PCR profiling data. Genomics 2006; 88: 173-184.
  CrossrefPubMedGoogle Scholar
• 27 Cao C, Lawrence DA, Li Y. et al. Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac- 1-dependent macrophage migration. EMBO J 2006; 25: 1860-1870.
  CrossrefPubMedGoogle Scholar